Non alcoholic fatty liver disease trang 1 tải miễn phí từ TAILIEUCHUNG

"Non alcoholic fatty liver disease" trang 1 - tải miễn phí từ Tailieuchung

Omega-3 fatty acids for treatment of non-alcoholic fatty liver disease: Design and rationale of randomized controlled trial

Omega-3 fatty acids for treatment of non-alcoholic fatty liver disease: Design and rationale of randomized controlled trial

11 71 3

Associations between nut intake, cognitive function and non‐alcoholic fatty liver disease (NAFLD) in older adults in the United States: NHANES 2011-14

Associations between nut intake, cognitive function and non‐alcoholic fatty liver disease (NAFLD) in older adults in the United States: NHANES 2011-14

12 10 1

Possible association of arrestin domain-containing protein 3 and progression of non-alcoholic fatty liver disease

Possible association of arrestin domain-containing protein 3 and progression of non-alcoholic fatty liver disease

13 60 0

Phenotypic alteration of hepatocytes in non-alcoholic fatty liver disease

Phenotypic alteration of hepatocytes in non-alcoholic fatty liver disease

9 49 0

Pediatric non alcoholic fatty liver disease: More on novel treatment targets

Pediatric non alcoholic fatty liver disease: More on novel treatment targets

2 45 0

Analysis of the dietary factors associated with suspected pediatric nonalcoholic fatty liver disease and potential liver fibrosis: Korean National Health and Nutrition Examination Survey 2014-2017

Analysis of the dietary factors associated with suspected pediatric nonalcoholic fatty liver disease and potential liver fibrosis: Korean National Health and Nutrition Examination Survey 2014-2017

10 72 0

Ultrasound/Elastography techniques, lipidomic and blood markers compared to Magnetic Resonance Imaging in non-alcoholic fatty liver disease adults

Ultrasound/Elastography techniques, lipidomic and blood markers compared to Magnetic Resonance Imaging in non-alcoholic fatty liver disease adults

9 45 0

Pediatric non alcoholic fatty liver disease: Old and new concepts on development, progression, metabolic insight and potential treatment targets

Pediatric non alcoholic fatty liver disease: Old and new concepts on development, progression, metabolic insight and potential treatment targets

10 66 0

Normal serum alanine aminotransferase and non-alcoholic fatty liver disease among Korean adolescents: A cross-sectional study using data from KNHANES 2010–2015

Normal serum alanine aminotransferase and non-alcoholic fatty liver disease among Korean adolescents: A cross-sectional study using data from KNHANES 2010–2015

5 60 0

Is there an association between nonalcoholic fatty liver disease and cognitive function? A systematic review

Is there an association between nonalcoholic fatty liver disease and cognitive function? A systematic review

19 9 1

A low follicle-stimulating hormone level is a protective factor for non-alcoholic fatty liver disease in older men aged over 80

A low follicle-stimulating hormone level is a protective factor for non-alcoholic fatty liver disease in older men aged over 80

10 12 1

Non-alcoholic fatty liver disease is associated with low-grade albuminuria in men without diabetes mellitus

Non-alcoholic fatty liver disease is associated with low-grade albuminuria in men without diabetes mellitus

7 83 0

Beneficial role of bioactive lipids in the pathobiology, prevention, and management of HBV, HCV and alcoholic hepatitis, NAFLD, and liver cirrhosis: A review

Beneficial role of bioactive lipids in the pathobiology, prevention, and management of HBV, HCV and alcoholic hepatitis, NAFLD, and liver cirrhosis: A review

13 93 0

Intra-abdominal fat is related to metabolic syndrome and non-alcoholic fat liver disease in obese youth

Intra-abdominal fat is related to metabolic syndrome and non-alcoholic fat liver disease in obese youth

6 80 0

A randomised, double-blind, placebocontrolled phase 1 study of the safety, tolerability and pharmacodynamics of volixibat in overweight and obese but otherwise healthy adults: Implications for treatment of non-alcoholic steatohepatitis

A randomised, double-blind, placebocontrolled phase 1 study of the safety, tolerability and pharmacodynamics of volixibat in overweight and obese but otherwise healthy adults: Implications for treatment of non-alcoholic steatohepatitis

13 46 0

Changes of intestinal bacterial microbiota in coronary heart disease complicated with nonalcoholic fatty liver disease

Changes of intestinal bacterial microbiota in coronary heart disease complicated with nonalcoholic fatty liver disease

12 33 1

Palmitate induced regulation of PPARγ via PGC1α: A mechanism for lipid accumulation in the liver in non-alcoholic fatty liver disease

Palmitate induced regulation of PPARγ via PGC1α: A mechanism for lipid accumulation in the liver in non-alcoholic fatty liver disease

10 45 0

Pharmacokinetic and metabolomic analyses of Mangiferin calcium salt in rat models of type 2 diabetes and non-alcoholic fatty liver disease

Pharmacokinetic and metabolomic analyses of Mangiferin calcium salt in rat models of type 2 diabetes and non-alcoholic fatty liver disease

12 73 1

Increased liver echogenicity and liver enzymes are associated with extreme obesity, adolescent age and male gender: Analysis from the German/Austrian/Swiss obesity registry APV

Increased liver echogenicity and liver enzymes are associated with extreme obesity, adolescent age and male gender: Analysis from the German/Austrian/Swiss obesity registry APV

10 94 0

Rhododendron oldhamii leaf extract improves fatty liver syndrome by increasing lipid oxidation and decreasing the lipogenesis pathway in mice

Rhododendron oldhamii leaf extract improves fatty liver syndrome by increasing lipid oxidation and decreasing the lipogenesis pathway in mice

9 58 0

Đã phát hiện trình chặn quảng cáo AdBlock

Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.